Atlas Trials

PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma

Clinical trial NCT06696742 · RECRUITING

Trial details

NCT number
NCT06696742
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder (Urothelial, Transitional Cell) Cancer
Start date
2024-02-01
Primary completion
2029-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.